XML 120 R46.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment Data (Tables)
12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Summary of Net Sales and Other Information by Segment

Net sales and other information by segment is as follows (in millions):

 

 

Americas

 

 

EMEA

 

 

Asia

Pacific

 

 

Immaterial

Product

Category

Operating

Segments

 

 

Global

Operations

and

Corporate

Functions

 

 

Total

 

For the Year Ended December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

3,978.1

 

 

$

1,538.6

 

 

$

1,297.0

 

 

$

1,168.5

 

 

$

-

 

 

$

7,982.2

 

Depreciation and amortization

 

 

109.3

 

 

 

71.0

 

 

 

65.2

 

 

 

45.5

 

 

 

715.1

 

 

 

1,006.1

 

Segment operating profit

 

 

2,163.2

 

 

 

477.1

 

 

 

458.9

 

 

 

208.2

 

 

 

(1,124.1

)

 

 

2,183.3

 

Inventory and manufacturing-related charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(53.9

)

Intangible asset amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(584.3

)

Intangible asset impairment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(70.1

)

Quality remediation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(82.4

)

Restructuring and other cost reduction initiatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(50.0

)

Acquisition, integration and related

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(12.2

)

Litigation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(65.0

)

Litigation settlement gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23.5

 

European Union Medical Device Regulation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(30.9

)

Other charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(120.5

)

Operating profit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,137.5

 

For the Year Ended December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

3,932.6

 

 

$

1,576.1

 

 

$

1,236.9

 

 

$

1,187.3

 

 

$

-

 

 

$

7,932.9

 

Depreciation and amortization

 

 

120.4

 

 

 

70.3

 

 

 

66.6

 

 

 

45.0

 

 

 

738.2

 

 

 

1,040.5

 

Segment operating profit

 

 

2,084.4

 

 

 

479.3

 

 

 

435.3

 

 

 

206.6

 

 

 

(995.3

)

 

 

2,210.3

 

Inventory and manufacturing-related charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(32.5

)

Intangible asset amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(595.9

)

Goodwill and intangible asset impairment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(979.7

)

Quality remediation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(165.4

)

Restructuring and other cost reduction initiatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(34.2

)

Acquisition, integration and related

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(99.5

)

Litigation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(186.0

)

European Union Medical Device Regulation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3.7

)

Other charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(79.6

)

Operating profit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

33.8

 

For the Year Ended December 31, 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

3,928.9

 

 

$

1,523.4

 

 

$

1,158.3

 

 

$

1,192.7

 

 

$

-

 

 

$

7,803.3

 

Depreciation and amortization

 

 

127.6

 

 

 

71.7

 

 

 

60.2

 

 

 

45.7

 

 

 

757.5

 

 

 

1,062.7

 

Segment operating profit

 

 

2,126.8

 

 

 

478.1

 

 

 

417.6

 

 

 

262.9

 

 

 

(859.8

)

 

 

2,425.6

 

Inventory step-up and other inventory and manufacturing-related charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(70.8

)

Intangible asset amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(603.9

)

Goodwill and intangible asset impairment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(331.5

)

Quality remediation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(195.1

)

Restructuring and other cost reduction initiatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(17.6

)

Acquisition, integration and related

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(262.2

)

Litigation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(104.0

)

Other charges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(41.2

)

Operating profit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

799.3

 

 

Disclosure on Geographic Areas, Long-Lived Assets

We conduct business in the following countries that hold 10 percent or more of our total consolidated Property, plant and equipment, net (in millions):

 

 

 

As of December 31,

 

 

 

2019

 

 

2018

 

United States

 

$

1,295.0

 

 

$

1,235.1

 

Other countries

 

 

782.4

 

 

 

780.3

 

Property, plant and equipment, net

 

$

2,077.4

 

 

$

2,015.4